Vertex Pharmaceuticals Incorporated VRTX Casgevy Commercial Momentum and Pipeline Catalysts Signal Upside Ahead of Partner CRISPR Therapeutics Q1 2026 Earnings Should investors consider Abacus Global ABX stock right now Q4 2025 Earnings Beat Estimates REFR Research shares fall 396 following Q2 2025 earnings release with no analyst consensus estimates available